×
-0.00438596491228076 -0.031578947368421 -0.031578947368421 -0.031578947368421 -0.031578947368421 -0.031578947368421 -0.0192982456140351 -0.0192982456140351
Stockreport

Sol-Gel’s Phase 2 Data on TWIN and VERED to be Presented at the 2018 American Academy of Dermatology Annual Meeting

SOL-GEL TECHNOLOGIES LTD ORDINARY SHARES (SLGL)  More Company Research Source: GlobeNewswire
PDF NESS ZIONA, Israel, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (“Sol-Gel”) (NASDAQ:SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced that data will be presented from the company’s Phase 2 clinical trial for TWIN in the treatment of acne and also from its Phase 2 clinical trial for VERED in the treatment of subtype II rosacea at the 2018 American Academy of Dermatology (AAD) Annual Meeting taking place February 16-20 in San Diego, California. The TWIN Phase 2 trial was a six-arm, randomized, double-blind, placebo-controlled clinical trial that enrolled 726 subjects at 36 sites in the United States. The trial evaluated the efficacy, tolerability and safety of two TWIN concentrations, TWIN High and TWIN Low, containing a higher or lower concentration of encapsulated tretinoin and an identical concentration of encapsulated benzo [Read more]

IMPACT SNAPSHOT EVENT TIME: SLGL
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
SLGL alerts
from News Quantified
Opt-in for
SLGL alerts

from News Quantified
Opt-in for
SLGL alerts

from News Quantified